Compare Novartis AG (NVS) vs Palo Alto Networks Inc (PANW) Price & Performance

Novartis AGTrade

Palo Alto Networks IncTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Palo Alto Networks Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Palo Alto Networks Inc trades at $341.44 (market cap $284.16B). The key difference: Novartis AG and Palo Alto Networks Inc are close in size by market cap, and Novartis AG pays a 3.17% dividend while Palo Alto Networks Inc pays none. Which is the better fit depends on your goals.

	NVS	PANW
Market Cap	$290.25B	$284.16B
Sector	Health	Technology
52-Week High	$168.62	$358.68
52-Week Low	$113.50	$141.67
Enterprise Value	$330.27B	$283.12B
Dividend Yield	3.17%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVS

Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.Gordon Thompson · 23 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral FDA approves Fabhalta as first drug to significantly slow kidney decline in IgAN patientsNovartis · 4 days agoBullish View details →

PANW

Palo Alto Networks to acquire Embrace, adding Real User Monitoring and Synthetics to boost app performance insights.PRNewsWire · 5 hours agoBullish Argus Research raises Palo Alto Networks price target to $425 on booming AI-driven cybersecurity demand.Danny Green · 6 hours agoBullish Cybersecurity ETFs soar as investors shift from semiconductors amid rising cyber threats and AI risks.ETF Trends · 7 hours agoBullish View details →

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

About Palo Alto Networks Inc

Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.